NASDAQ: MURAMural Oncology PLC Earnings Dates, Reports, Calls
Mural Oncology earnings were -$130.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest MURA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$33.1M, down 3.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MURA reported annual earnings of -$128.5M, with -38% growth.
MURA earnings history
Current Revenue
$0.0
Current Earnings
-$130.7M
Current Profit Margin
0%
MURA Return on Equity
Current Company
-83.4%
Current Industry
-60.2%
Current Market
31.5%
MURA's Return on Equity (-83.4%)... subscribe to Premium to read more.
High Return on Equity Performance
MURA undefined
Current Company
-70.7%
Current Industry
-2.5%
MURA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when MURA announces earnings.
MURA undefined
Current Company
-120.02%
Current Industry
5.8%
MURA vs Biotech Stocks
Mural Oncology Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.